Here are five key notes:
1. Dr. Yamada most recently served as the chief medical and scientific officer of Takeda Pharmaceuticals.
2. Prior to Takeda, Dr. Yamada was the president of the Global Health Program at the Bill & Melinda Gates Foundation.
3. Dr. Lengauer is the current chief scientific officer of Blueprint Medicines, a public personalized medicine company.
4. He was previously vice president and global head of oncology drug discovery and preclinical development at Sanofi.
5. Presage Biosciences is an oncology company pioneering the incorporation of human efficacy data earlier in the drug development and clinical trial processes.
More articles on GI/endoscopy:
4 GI physicians in the news – Nov. 20, 2015
AstraZeneca sells Crohn’s drug US rights for $380M
Defining moments: The top 2015 highlights in GI
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.